Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05037370 · ClinicalTrials.gov registry record · NA
CONTOURA vs WFO Ablation PRK & LASIK
A NA study of Refractive Surgery, sponsored by 59th Medical Wing.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05037370: Recruiting NA study of Refractive Surgery, sponsored by 59th Medical Wing.
NCT05037370 is a NA study of Refractive Surgery that is actively recruiting participants, run by 59th Medical Wing. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05037370, a NA study of Refractive Surgery, is actively recruiting participants, sponsored by 59th Medical Wing.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ablation profile provides the best visual outcome.
Primary Outcome
The Post-Operative sphere equivalent refractive error for eyes undergoing Wave-Front Optimized (WFO) ablation vs Topography-guided ablation
Conditions Studied
Interventions
- DEVICE Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation
Study Locations (1)
Texas
- Joint Warfighter Refractive Surgery Center at WHASC - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05037370 shows while recruiting
NCT05037370 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Refractive Surgery appearing as the primary indexed condition, and to 1 intervention - of which Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation is the first listed.
NCT05037370 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05037370 about?
NCT05037370 is a clinical study titled "CONTOURA vs WFO Ablation PRK & LASIK". This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ab...
What is the current status of trial NCT05037370?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2021-04-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05037370 study?
This clinical trial studies the following conditions: Refractive Surgery.
What interventions are being tested in trial NCT05037370?
The interventions under investigation include: Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation (DEVICE).
Who is sponsoring clinical trial NCT05037370?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05037370 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05037370's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
RECRUITING · NA
-
Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI